Description: Ticagrelor is the first reversibly binding oral P2Y12 receptor antagonist with Ki of 2 nM. Ticagrelor / AZD-6140 / AR-C 126532XX is a platelet aggregation inhibitor drug produced by AstraZeneca and was approved in 2011.
Catalog | OFC274693275 |
CAS | 274693-27-5 |
Category | Fluorinated APIs |
Synonyms | Brilique |
Purity | >98% |
※ Please kindly note that our products are for research use only.
IUPAC Name | (1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-propylsulfanyltriazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
InChI | InChI=1S/C23H28F2N6O4S/c1-2-7-36-23-27-21(26-15-9-12(15)11-3-4-13(24)14(25)8-11)18-22(28-23)31(30-29-18)16-10-17(35-6-5-32)20(34)19(16)33/h3-4,8,12,15-17,19-20,32-34H,2,5-7,9-10H2,1H3,(H,26,27,28)/t12-,15+,16+,17-,19-,20+/m0/s1 |
InChI Key | OEKWJQXRCDYSHL-FNOIDJSQSA-N |
Isomeric SMILES | CCCSC1=NC(=C2C(=N1)N(N=N2)[C@@H]3C[C@@H]([C@H]([C@H]3O)O)OCCO)N[C@@H]4C[C@H]4C5=CC(=C(C=C5)F)F |
EC Number | 619-540-9 |
Molecular Formula | C23H28F2N6O4S |
Molecular Weight | 522.57 |
Appearance | White to off-white solid powder |
XLogP3-AA | 2 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 12 |
Rotatable Bond Count | 10 |
Exact Mass | 522.18608089 g/mol |
Monoisotopic Mass | 522.18608089 g/mol |
Topological Polar Surface Area | 164Ų |
Heavy Atom Count | 36 |
Formal Charge | 0 |
Complexity | 736 |
Please kindly note that our products and services are for research use only.